Loading…

Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing

Angiogenic imbalances, characterized by an excess of antiangiogenic factors (soluble fms-like tyrosine kinase 1) and reduced angiogenic factors (vascular endothelial growth factor and placental growth factor), contribute to the mechanisms of disease in preeclampsia. The ratio of soluble fms-like tyr...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2024-09, Vol.231 (3), p.363.e1-363.e11
Main Authors: Espinoza, Jimmy, Calsavara, Vinicius F., Kilpatrick, Sarah, Rana, Sarosh, Costantine, Maged M., Boggess, Kim, Wylie, Blair J., Moore Simas, Tiffany A., Louis, Judette M., Gaw, Stephanie L., Murtha, Amy, Wiegand, Samantha, Gollin, Yvonne, Singh, Deepjot, Silver, Robert M., Durie, Danielle E., Panda, Britta, Norwitz, Errol R., Burd, Irina, Plunkett, Beth, Scott, Rachel K., Lemoine, Elizabeth, Thadhani, Ravi, Karumanchi, S. Ananth
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiogenic imbalances, characterized by an excess of antiangiogenic factors (soluble fms-like tyrosine kinase 1) and reduced angiogenic factors (vascular endothelial growth factor and placental growth factor), contribute to the mechanisms of disease in preeclampsia. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor has been used as a biomarker for preeclampsia, but the cutoff values may vary with gestational age and assay platform. This study aimed to compare multiples of the median of the maternal plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio, soluble fms-like tyrosine kinase 1, placental growth factor, and conventional clinical and laboratory values in their ability to predict preeclampsia with severe features. We conducted a cohort study across 18 United States centers involving hospitalized individuals with hypertension between 23 and 35 weeks’ gestation. Receiver operating characteristic curve analyses of maternal plasma biomarkers, highest systolic or diastolic blood pressures, and laboratory values at enrollment were performed for the prediction of preeclampsia with severe features. The areas under the curve were compared, and quasi-Poisson regression models were fitted to estimate relative risks. The primary outcome was preeclampsia with severe features within 2 weeks of enrollment. Secondary outcomes were a composite of severe adverse maternal outcomes (elevated liver enzymes, low platelets count, placental abruption, eclampsia, disseminated intravascular coagulation, and pulmonary edema) and a composite of severe adverse perinatal outcomes (birth weight below the third percentile, very preterm birth [
ISSN:0002-9378
1097-6868
1097-6868
DOI:10.1016/j.ajog.2024.05.050